SUSTAIN III DIN 02224194
Health Canada record
| Active ingredient(s) | SULFAMETHAZINE 32.1 G |
|---|---|
| Dosage form | Bolus |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 25-Oct-1996 |
| Current status date | 13-Aug-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SULFAMETHAZINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01908375 | CALFSPAN TABLETS | CAN-VET ANIMAL HEALTH SUPPLIES LTD. | Tablet (Extended-Release) | SULFAMETHAZINE 8 G | Marketed |
| 02443678 | CALFSTRONG TABLETS | INLAND VETERINARY SUPPLY LTD. | Tablet (Extended-Release) | SULFAMETHAZINE 8 G | Approved |
| 00084581 | AUREO S 700 | CYANAMID CANADA INC. | Powder | SULFAMETHAZINE 77 G; CHLORTETRACYCLINE 77 G | Cancelled Post Market |
| 00695637 | CALFSPAN TAB 8GM SUSTAINED RELEASE | NORDEN LABORATORIES INC. | Tablet (Extended-Release) | SULFAMETHAZINE 8 G | Cancelled Post Market |
| 00419036 | HAVA SPAN SRT/SULFA SPAN 22.5GM | BAYVET, DIVISION OF CHEMAGRO LTD. | Tablet (Extended-Release) | SULFAMETHAZINE 22.5 G | Cancelled Post Market |
| 02169533 | HAVA-SPAN - BOLUS 22.5GM | BAYER INC., ANIMAL HEALTH | Tablet | SULFAMETHAZINE 22.5 G | Cancelled Post Market |
| 00346632 | NEUTRAL SULFA 50 | PROFESSIONAL VETERINARY LABORATORIES | Solution | SULFAMETHAZINE 45 MG; SULFATHIAZOLE 45 MG; SULFAPYRIDINE 20 MG | Dormant |
| 02240309 | NEUTRAL SULFA 7 | PROFESSIONAL VETERINARY LABORATORIES | Liquid | SULFAMETHAZINE 45 MG; SULFATHIAZOLE 45 MG; SULFAPYRIDINE 20 MG | Dormant |
| 00251828 | SULFAMETHAZINE BOLUS | DOMINION VETERINARY LABORATORIES LTD. | Bolus | SULFAMETHAZINE 15 G | Dormant |
| 00308382 | SULFAMETHAZINE BOLUS | PROFESSIONAL VETERINARY LABORATORIES | Bolus | SULFAMETHAZINE 15 G | Dormant |
| 00336009 | SULFAMETHAZINE SPANBOLET 2 SRT | NORDEN LABORATORIES INC. | Tablet (Extended-Release) | SULFAMETHAZINE 27 G | Cancelled Post Market |
| 02213850 | SULFASURE SR CALF TABLET (8.25G) SRT | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Tablet (Extended-Release) | SULFAMETHAZINE 8.25 G | Cancelled Post Market |
| 00874523 | SULKA-S BOLUS 5GM | NORDEN LABORATORIES INC. | Tablet | SULFAMETHAZINE 5 G | Cancelled Post Market |
| 00313270 | SULKAMYCIN S BOLETTES | NORDEN LABORATORIES INC. | Tablet | SULFAMETHAZINE 2 G; NEOMYCIN SULFATE 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20352 | 2018-01-18 | Supplement to a New Drug Submission (SNDS) | CHANGE TO PRESCRIPTION STATUS. LABELLING UPDATES |
| 6255 | 2001-02-01 | New Drug Submission (NDS) | |
| 6927 | 1998-07-02 | New Drug Submission (NDS) | |
| 7063 | 1996-07-05 | New Drug Submission (NDS) |
International API supply for SULFAMETHAZINE
1 active FDA Drug Master Files.
Request a quote for SUSTAIN III